Suzlon Q4 FY17

Revenue 

• FY17 Rs. 12,693 cr  v/s  Rs. 9,430 cr in FY16; 35% growth Y-o-Y
• Q4 FY17 Rs. 4,993 cr v/s  Rs. 3,219 cr in Q4 FY16

Operating Performance (EBITDA*) 

• FY17 EBITDA of Rs. 2,203 cr,   EBITDA margin of 17%
• Q4 FY17 EBITDA at Rs. 722 cr, EBITDA margin at 15%

Consolidated Net Term Debt (excluding FCCB)

•  FY17 at Rs. 6,198 cr down from Rs. 6,528 cr in FY16

Suzlon is nearly out of the debt restructuring process. 

It has also sold the Hansen gearbox company.
The company has also raised `1,800 cr from Dilip Shangvi’s Sun Pharma group. 

These initiatives have helped the company to reduce its debt by almost 50%. The present debt stands at about $1 billion.
The company has sold Germany’s REpower (later renamed Senvion). 

The company hopes to pay majority of the debt, which are back ended, in parts in the next 5 or 6 years.

 Suzlon is now in a very comfortable position to service its debt. 

The company would submit its audited numbers to the banks in May.

 After that, banks would clear the proposals to come out of corporate debt restructuring. 

It should happen in the next three months, depending on how long the banks take to process the proposals.